All persons or entities that purchased or acquired Axsome Therapeutics, Inc. (“Axsome”) common stock during the period from May 10, 2021 to April 22, 2022, inclusive.
Final Approval
May 10, 2021 - July 22, 2022
February 10, 2026
January 13, 2026
Strategic Claims Services
600 N. Jackson St., Ste. 205
P.O. Box 230
Media, PA 19063
+1 866-274-4004
[email protected]
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.